SCHEMBL13040039

SCHEMBL13040039

CC(C)N(CC(COc1cccc2ccccc12)OC(=O)CCCO[N+](=O)[O-])C(=O)CCCO[N+](=O)[O-]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR2E1 Q9Y466 3/20 0.37
▸ ACKR3 P25106 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ CNR1 P21554 1/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ABCB1 P08183 2/20 0.36
▸ CYP2D6 P10635 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ ADRB2 P07550 1/20 0.35
▸ ADRB1 P08588 1/20 0.35
▸ ADRB3 P13945 1/20 0.35
▸ HTR1B P28222 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ SCN1A P35498 1/20 0.35
▸ HTR2B P41595 1/20 0.35
▸ HTR6 P50406 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14571135 0.87 NR2E1 (0.46) NR2E1TSHRKMT2AABCB1CYP2D6
SCHEMBL13077340 0.86 NR2E1 (0.39) NR2E1ACKR3TSHRCNR1CNR2
SCHEMBL13040093 0.86 HTR1A (0.42) TSHRKMT2ACYP2D6ALDH1A1CYP1A2
SCHEMBL3259801 0.83 NR2E1 (0.55) NR2E1TSHRCNR1CNR2KMT2A
SCHEMBL13040109 0.77 NPY1R (0.37) CYP2D6ADRB2ADRB1ADRB3HTR2A
SCHEMBL14117389 0.77 NR2E1 (0.52) NR2E1TSHRKMT2AABCB1CYP2D6
SCHEMBL13040066 0.77 ADRB2 (0.43) CYP2D6ADRB2ADRB1HTR2A
SCHEMBL14571120 0.75 ADRB2 (0.40) KMT2AALDH1A1ADRB2ADRB1ADRB3
SCHEMBL13149057 0.74 NR2E1 (0.41) NR2E1TSHRKMT2AABCB1CYP2D6
SCHEMBL14571109 0.73 ADRA2A (0.35) CYP2D6CYP1A2HTR1BSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825263-B2 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive NICOX S.A. (FR) 2010-11-02 — — US disclosed
US-20070072854-A1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive NICOX S.A. (FR) 2007-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072854-A1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive ADRB2, ADRB1, ADRA2B NR2E1 953/4885ACKR3 2664/4885TSHR 2786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback